<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The kinetics of ATP release from Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> target cells following complement activation by rat monoclonal IgM antibody have been used to develop a standard assay for antibody-complement mediated cytotoxicity </plain></SENT>
<SENT sid="1" pm="."><plain>This assay permitted the study of the reactivity of the monoclonal IgM with Burkitt and non-Burkitt cell lines and to perform IgM-complement mediated cytotoxicity inhibition experiments with <z:chebi fb="2" ids="50699">oligosaccharides</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>This led to a precise definition of the antigenic determinant recognized by the monoclonal IgM on globotriaosylceramide </plain></SENT>
</text></document>